Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05329103
What this trial is testing

Evaluate PEEL-224 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Peel Therapeutics Inc 65
Testing effectiveness (Phase 2)UnknownNCT05887726
What this trial is testing

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Who this might be right for
Diffuse Large B Cell Lymphoma
Liaoning Cancer Hospital & Institute 30
Early research (Phase 1)Ended earlyNCT06487858
What this trial is testing

BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

Who this might be right for
Solid Tumor
BeOne Medicines 42
Early research (Phase 1)UnknownNCT04146610
What this trial is testing

Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors

Who this might be right for
Neoplasms
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT05103917
What this trial is testing

Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Who this might be right for
Triple Negative Breast Cancer
Abbisko Therapeutics Co, Ltd 24
Early research (Phase 1)Looking for participantsNCT07222267
What this trial is testing

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Who this might be right for
Breast CancerAdvanced Solid Tumor
BeOne Medicines 86
Testing effectiveness (Phase 2)Looking for participantsNCT07421700
What this trial is testing

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Who this might be right for
Urothelial CancerAdvanced/Metastatic Urothelial CancerUrothelial Carcinoma
Pfizer 132
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Testing effectiveness (Phase 2)Ended earlyNCT03037645
What this trial is testing

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytoid Lymphoma+5 more
Sunesis Pharmaceuticals 39
Early research (Phase 1)Looking for participantsNCT06034275
What this trial is testing

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaHigh-risk Myelodysplastic Syndrome
Vincerx Pharma, Inc. 36
Early research (Phase 1)Looking for participantsNCT07524322
What this trial is testing

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+6 more
Regor Pharmaceuticals Inc. 63
Early research (Phase 1)Study completedNCT05685472
What this trial is testing

MEDI5752 in Japanese Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
AstraZeneca 6
Testing effectiveness (Phase 2)Ended earlyNCT00627419
What this trial is testing

A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Infinity Pharmaceuticals, Inc. 1
Early research (Phase 1)UnknownNCT03529526
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Alphamab (Australia) Co Pty Ltd. 21
Testing effectiveness (Phase 2)Looking for participantsNCT06155084
What this trial is testing

Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 84
Early research (Phase 1)Looking for participantsNCT07281326
What this trial is testing

AK138D1 in Advanced Malignant Tumors

Who this might be right for
Solid Cancer
Akeso 200
Early research (Phase 1)Looking for participantsNCT07226349
What this trial is testing

BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 105
Early research (Phase 1)Study completedNCT05712889
What this trial is testing

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 29
Early research (Phase 1)Study completedNCT02503774
What this trial is testing

MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.

Who this might be right for
Solid Tumors
MedImmune LLC 192
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Next Page